patho exam 3

Pneumonia

  • Definition: Inflammation of the lung parenchyma due to infection by bacteria (e.g., Streptococcus pneumoniae), viruses, and fungi.

  • Statistics: 3rd leading cause of death worldwide.

Pathophysiology

  • Mechanism: Pathogen enters alveoli, triggering an inflammatory response.

  • Effects: Fluid accumulation impairs gas exchange.

  • Immune Activation: Leads to systemic symptoms.

Clinical Presentation

  • Common symptoms include:

    • Fever

    • Cough with sputum

    • Dyspnea (shortness of breath)

    • Chest pain

    • Malaise (general discomfort)

Management

  • Bacterial Pneumonia: Administer antibiotics (e.g., penicillin).

  • Supportive Care: Provide oxygen (O2), fluids, bronchodilators.

Types

  • Community-Acquired Pneumonia (CAP) : Acquired outside healthcare settings.

  • Hospital-Acquired Pneumonia (HAP) : Acquired during hospital stays.

  • Aspiration Pneumonia: Due to aspiration of foreign material (e.g., food, liquid).

Diagnosis

  • Methods:

    • Chest X-ray

    • Sputum culture

    • Blood tests

Tuberculosis (TB)

  • Definition: Chronic infectious disease caused by Mycobacterium tuberculosis.

Pathophysiology

  • Mechanism:

    • TB bacilli invade alveolar macrophages, evading immune destruction.

    • Granuloma formation can lead to latent TB or active disease.

    • Lung tissue damage results in cavitation and fibrosis.

Transmission

  • Airborne droplets are the primary method of spread.

Risk Factors

  • Immunosuppression (e.g., HIV/AIDS), malnutrition, and crowded living conditions.

Clinical Presentation

  • Common symptoms:

    • Chronic cough

    • Weight loss

    • Night sweats

    • Hemoptysis (coughing up blood)

Diagnosis

  • Methods:

    • Chest X-ray

    • Sputum Acid-Fast Bacilli (AFB) smear and culture

    • Tuberculin skin test (TST)

    • Interferon-Gamma Release Assay (IGRA)

Management

  • 1st Line Anti-TB Drugs (RIPE):

    • Rifampin

    • Isoniazid

    • Pyrazinamide

    • Ethambutol

  • Directly Observed Therapy (DOT): Ensures adherence to treatment.

Asthma

  • Definition: Chronic inflammatory airway disorder characterized by reversible bronchoconstriction.

Triggers

  • Common triggers include allergens, infections, cold air, exercise, and stress.

Types

  • Allergic and non-allergic asthma.

Pathophysiology

  • Airway hyperresponsiveness leads to inflammation and mucus hypersecretion.

Clinical Presentation

  • Common symptoms:

    • Wheezing

    • Cough

    • Shortness of breath

    • Chest tightness

Status Asthmaticus

  • Definition: Life-threatening asthma exacerbation characterized by:

    • Acute severe bronchospasm

    • Worsening hypoxemia

    • Decreased ventilation, leading to cessation of air movement (silent chest).

  • Clinical Markers:

    • PaCO2 > 70 mm Hg, indicative of respiratory acidosis and respiratory failure.

    • Possible need for mechanical ventilation.

Chronic Obstructive Pulmonary Disease (COPD)

  • Statistics: 6th leading cause of death in the US, and the most common chronic lung disease.

Definition

  • Combination of emphysema and chronic bronchitis.

Pathophysiology

  • Airflow limitation, chronic inflammation, and progressive lung damage.

Clinical Presentation

  • Common symptoms:

    • Dyspnea

    • Chronic cough

    • Sputum production

    • Frequent exacerbations.

Pneumothorax

  • Types:

    • Spontaneous

    • Traumatic (most common)

    • Tension

Pathophysiology

  • Air enters pleural space, causing lung collapse and impaired ventilation.

Clinical Presentation

  • Symptoms include:

    • Sudden chest pain

    • Dyspnea

    • Diminished breath sounds

    • Tracheal deviation.

Management

  • Intervention: Chest tube insertion.

Pleural Effusion

  • Definition: Accumulation of fluid in the pleural space.

Types

  • Transudative: e.g., due to heart failure, cirrhosis.

  • Exudative: e.g., due to infection or malignancy.

Pathophysiology

  • Disruption in pleural fluid homeostasis leads to compression of lung tissue.

Clinical Presentation

  • Symptoms:

    • Dyspnea

    • Chest pain

    • Decreased breath sounds

Management

  • Intervention: Chest tube insertion.

Nephrotic Syndrome

  • Pathophysiology:

    • Damage to podocytes increases glomerular permeability.

    • Massive protein loss leads to hypoalbuminemia and edema.

    • Hyperlipidemia results from compensatory liver response.

Other Features

  • Proteinuria: > 3.5 g/day (massive)

  • Hematuria: None

  • Edema: Generalized (anasarca)

  • Blood Pressure: Normal/low

  • Common Causes: Diabetes, minimal change disease.

Nephritic Syndrome

  • Pathophysiology:

    • Immune complex deposition (Post-streptococcal, Systemic Lupus Erythematosus) causes glomerular inflammation.

    • Capillary damage results in hematuria (RBC casts) and mild proteinuria.

    • Inflammation leads to increased blood pressure and reduced GFR, triggering oliguria.

Other Features

  • Proteinuria: Mild to moderate

  • Hematuria: Yes (RBC casts)

  • Edema: Mild periorbital edema

  • Blood Pressure: Hypertension

  • Common Causes: Post-streptococcal glomerulonephritis, lupus.

Urinary Tract Infections (UTI)

  • Definition: Infection of the urinary tract (including bladder, ureters, kidneys), most commonly caused by E. coli (~80%).

Pathophysiology

  • Bacterial colonization results in urethral entry:

    • Cystitis: Localized bladder infection, resulting in frequency, dysuria, and urgency.

    • Pyelonephritis: Infection ascends to kidneys, causing inflammation, fever, and flank pain.

    • Chronic recurrent infections can lead to chronic pyelonephritis and renal scarring, ultimately causing chronic kidney disease (CKD).

Clinical Manifestations

  • Symptoms:

    • Dysuria

    • Suprapubic pain

    • Cloudy urine

    • Hematuria

    • Fever (in case of pyelonephritis)

Diagnosis

  • Methods:

    • Urinalysis

    • Urine culture

Management

  • Uncomplicated UTI: Nitrofurantoin, Trimethoprim-Sulfamethoxazole.

  • Pyelonephritis: IV antibiotics (e.g., ceftriaxone, fluoroquinolones).

Prevention

  • Hydration, proper hygiene (wiping front to back), cranberry supplements.

Urinary Tract Obstructions

  • Pathophysiology: Stasis of urine predisposes to infection and stone formation. Backpressure development interferes with renal blood flow and may destroy kidney tissue.

Clinical Manifestations

  • Symptoms include:

    • Pain

    • Signs and symptoms of UTI

    • Manifestations of renal dysfunction.

Acute Kidney Injury/Failure

  • Definition: Sudden decline in kidney function occurring over hours to days.

Causes

  • Prerenal: Hypovolemia, Congestive Heart Failure (CHF), shock.

  • Intrinsic: Acute tubular necrosis (ATN), glomerulonephritis, toxins.

  • Postrenal: Obstruction (stones, tumors, Benign Prostatic Hyperplasia - BPH).

Pathophysiology

  • Initial Mechanism: Hypoperfusion leads to ischemic injury.

  • Subsequent Effects: Inflammation and tubular damage occurs.

    • Reversible Changes: Tubular cell swelling, loss of brush border, tubular lumen dilation, epithelial simplification, and cellular regeneration.

    • Irreversible Changes: Tubular epithelial necrosis, denudation of the basement membrane, cortical necrosis, which may progress to chronic kidney disease.

Clinical Manifestations

  • Symptoms include:

    • Oliguria (< 400 mL/day)

    • Azotemia (elevated blood urea nitrogen - BUN, elevated creatinine)

    • Fluid overload

    • Hyperkalemia

    • Metabolic acidosis.

Management

  • Prerenal Causes: Fluid resuscitation.

  • Remove nephrotoxins.

  • Severe Cases: Dialysis.

Nursing Interventions

  • Monitoring urine output and laboratory results.

  • Managing fluid and electrolyte levels.

  • Educating patients about dietary considerations and medication adherence.

Chronic Kidney Disease/Failure

  • Definition: Gradual loss of kidney function over months or years.

Causes

  • Leading Cause: Diabetes mellitus.

  • Other causes: Hypertension (HTN), glomerulonephritis, polycystic kidney disease.

Pathophysiology

  • Nephron loss leads to compensatory hypertrophy of remaining nephrons.

  • Activation of Renin-Angiotensin-Aldosterone System (RAAS) causes hypertension.

  • Chronic inflammation leads to fibrosis and scarring.

Clinical Manifestations

  • Early Stage: Asymptomatic, proteinuria.

  • Late Stage: Uremia (symptoms of kidney failure), metabolic acidosis, hyperkalemia, cardiovascular complications (hypertension, left ventricular hypertrophy).

Complications

  • Cardiovascular disease is the leading cause of death associated with chronic kidney disease.

  • Electrolyte imbalances (e.g., hyperkalemia, hyponatremia).

  • Bone-mineral disorders, leading to secondary hyperparathyroidism.

  • Anemia due to erythropoietin deficiency.

Management

  • Lifestyle Modifications: Low-protein diet, blood pressure control.

  • Medications: ACE inhibitors, phosphate binders, erythropoietin (EPO) therapy.

  • Advanced Management: Dialysis and transplantation.

Nursing Interventions

  • Monitoring urine output and laboratory results.

  • Managing fluid and electrolyte levels.

  • Educating patients about dietary considerations and medication adherence.

Dialysis

  • Indications for Dialysis: AEIOU:

    • Acidosis

    • Electrolytes abnormalities

    • Intoxications

    • Overload

    • Uremia.

Types of Dialysis

  • Hemodialysis (HD):

    • Mechanism: Blood is filtered through a dialyzer.

    • Vascular Access: Through AV fistula, graft, or catheter.

    • Complications: Hypotension, infections, disequilibrium syndrome.

  • Peritoneal Dialysis (PD):

    • Mechanism: Dialysate is infused into the peritoneal cavity.

    • Types: Continuous Ambulatory (CAPD) and Automated (APD).

    • Complications: Peritonitis, catheter infections.

Kidney Transplantation

  • Eligibility: Indications include patients with end-stage kidney disease.

  • Types of Donors: Living vs. cadaveric donors.

  • Post-Transplant Care: Requires immunosuppressive therapy to prevent rejection.

Pulmonary Embolism (PE)

  • Definition: Blockage of the pulmonary artery by a clot.

Causes

  • Common causes include deep vein thrombosis, prolonged immobility, surgery, and cancer.

Pathophysiology

  • Mechanism: Clot obstruction leads to ventilation-perfusion mismatch and hypoxia.

Clinical Presentation

  • Symptoms include:

    • Sudden dyspnea (shortness of breath)

    • Pleuritic chest pain

    • Tachycardia

    • Hemoptysis (coughing up blood).

Renal Stone (Nephrolithiasis)

  • Definition: Hard mineral deposits that form in the renal system.

Types of Stones

  • Calcium Oxalate: Most common type of stone.

  • Uric Acid: Associated with gout.

  • Struvite: Related to infections.

  • Cystine: Caused by genetic disorders.

Pathophysiology

  • Develop due to supersaturation of urine with minerals, nucleation, crystal formation, and stone growth leading to obstruction.

Clinical Manifestations

  • Symptoms:

    • Severe flank pain (renal colic)

    • Hematuria (blood in urine)

    • Nausea/vomiting.

Diagnosis

  • Methods:

    • CT scan (gold standard)

    • Urinalysis.

Management

  • Hydration, pain control using NSAIDs or opioids.

  • Lithotripsy for large stones or surgical removal if obstructive.

Crohn’s Disease

  • Definition: Chronic inflammatory bowel disease affecting any part of the gastrointestinal tract.

Pathophysiology

  • Characterized by transmural inflammation and granuloma formation.

Clinical Manifestations

  • Symptoms include:

    • Abdominal pain

    • Diarrhea

    • Weight loss.

Complications

  • Potential complications include fistulas and strictures.

Management

  • Nutritional support, pain management, and medication administration (immunosuppressants, corticosteroids).

Ulcerative Colitis

  • Definition: Chronic inflammation limited to the colon and rectum.

Pathophysiology

  • Characterized by continuous mucosal inflammation.

Clinical Manifestations

  • Symptoms:

    • Bloody diarrhea

    • Abdominal pain.

Complications

  • Potential complications include toxic megacolon and colorectal cancer.

Nursing Management

  • Focus on pain relief, medication administration (aminosalicylates, corticosteroids), and fluid replacement.

Basal Metabolic Rate (BMR)

  • Definition: The amount of energy the body requires to maintain basic physiological functions at rest.

Factors Affecting BMR

  • Influenced by age, gender, body composition, and hormonal regulation (e.g., Thyroxine).

Clinical Importance

  • Used to estimate daily calorie needs for maintaining body weight.

Body Mass Index (BMI)

  • Definition: Measure of body fat based on height and weight.

Calculation

  • Formula: extBMI=racextWeight(kg)extHeight(m2)ext{BMI} = rac{ ext{Weight (kg)}}{ ext{Height (m}^2)}

Categories

  • Underweight: < 18.5

  • Normal Weight: 18.5 – 24.9

  • Overweight: 25 – 29.9

  • Obesity: ≥ 30

    • Class I: BMI 30.0 to 34.9

    • Class II: BMI 35.0 to 39.9

    • Class III or Extreme Obesity: BMI > 40.

Obesity

  • Definition: Abnormal or excessive fat accumulation.

Causes

  • Genetic factors, lifestyle habits, and hormonal imbalances.

Pathophysiology

  • Dysfunction of adipose tissue leads to insulin resistance and low-grade inflammation.

Complications

  • Increased risk of cardiovascular disease, diabetes mellitus, and hypertension.

Management

  • Lifestyle modifications, pharmacological interventions, and bariatric surgery for severe obesity.

Energy Balance

  • Formula: extEnergyIntake=extEnergyExpenditureext{Energy Intake} = ext{Energy Expenditure}

  • Positive Energy Balance: Leads to weight gain.

  • Negative Energy Balance: Leads to weight loss.

Factors Affecting Energy Balance

  • Diet, physical activity, and hormonal influences (e.g., insulin, leptin).

Consequences of Imbalance

  • Potential outcomes include obesity and malnutrition.

Malnutrition

  • Types:

    • Undernutrition (Protein-Energy Malnutrition)

    • Micronutrient Deficiencies.

Causes

  • Poor dietary intake, chronic illness, and socioeconomic factors.

Pathophysiology

  • Leads to muscle wasting, impaired immunity, and delayed wound healing.

Complications

  • Anemia, osteoporosis, and increased susceptibility to infections.

Diagnosis

  • Methods include:

    • Clinical examinations

    • Anthropometric Measurements (BMI, Waist-to-Hip Ratio)

    • Laboratory Tests (Albumin, Hemoglobin, Electrolytes)

    • Dietary History

    • Nutritional Screening Tools (MUST, MNA).

Management

  • Nutritional counseling, dietary modifications, and physical activity recommendations. Medical treatment if necessary, along with community and public health programs advocating health education and awareness.

Heart Failure

  • Definition: The heart is unable to pump blood efficiently to meet bodily needs, leading to congestion in the lungs and/or systemic circulation.

Pathophysiology

  • Types of Heart Failure:

    • Systolic Heart Failure: Inadequate contraction of the heart muscle; reduced ejection fraction (EF) < 40%.

    • Diastolic Heart Failure: Impaired relaxation and filling; normal or near-normal ejection fraction.

    • Compensatory mechanisms (e.g., SNS activation influencing heart rate, and RAAS activation influencing blood volume) worsen heart failure by causing fluid retention, edema, and increased workload.

    • Left-Sided Heart Failure: Inadequate pumping by the left ventricle, leading to pulmonary congestion leading to:

    • Clinical manifestations including shortness of breath, orthopnea, paroxysmal nocturnal dyspnea, crackles in the lungs, fatigue.

    • Right-Sided Heart Failure: Inadequate pumping by the right ventricle leading to systemic fluid retention and:

    • Clinical manifestations including peripheral edema, jugular venous distension, hepatomegaly, ascites.

    • Congestive Heart Failure: Combination of left and right heart failure resulting in widespread fluid retention.

Risk Factors

  • Include hypertension (HTN), coronary artery disease (CHD), myocardial infarction (MI), valvular heart disease, diabetes, and obesity.

Management

  • Pharmacological Treatment: Includes diuretics (for fluid overload), ACE inhibitors, beta-blockers, vasodilators, and aldosterone antagonists.

  • Surgical intervention: May involve heart transplant in severe cases.

Shock

  • Definition: A life-threatening condition where tissue perfusion is inadequate leading to cellular hypoxia and organ dysfunction.

Pathophysiology

  • Stages of Shock:

    • Initial Stage: Reduced perfusion, leading to decreased oxygen and anaerobic metabolism; lactic acidosis develops.

    • Compensatory Stage: Sympathetic activation leads to increased heart rate and vasoconstriction, along with RAAS activation causing fluid retention.

    • Progressive Stage: Cellular dysfunction occurs alongside capillary leakage and organ hypoperfusion.

    • Irreversible Stage: Results in multiorgan failure and can lead to death.

Types of Shock

  • Hypovolemic Shock: Due to blood/fluid loss (e.g., hemorrhage, dehydration). Hemodynamic effect: decreased preload, decreased cardiac output, and decreased blood pressure.

  • Cardiogenic Shock: Due to heart pump failure (e.g., myocardial infarction or cardiomyopathy). Hemodynamic effect: decreased cardiac output, increased central venous pressure, pulmonary congestion.

  • Distributive Shock: Resulting from abnormal vasodilation (e.g., sepsis, anaphylaxis, neurogenic shock), leading to reduced systemic vascular resistance (SVR) and blood pressure.

  • Obstructive Shock: Due to mechanical obstruction (e.g., pulmonary embolism, cardiac tamponade), leading to decreased cardiac output and increased central venous pressure, reducing perfusion.

Clinical Manifestations

  • Symptoms include tachycardia, hypotension, cool clammy skin (except in septic shock), rapid shallow breathing, decreased urine output, and altered mental status.

Management

  • Monitor vital signs, perfusion, and urine output.

  • Support airway-breathing-circulation (ABC’s). Administer fluids and medications as per protocol. Educate about signs of early recognition of shock.

Deep Vein Thrombosis (DVT)

  • Definition: Formation of a blood clot in deep veins, commonly found in the legs.

Risk Factors (Virchow’s Triad)

  • Venous Stasis: Caused by immobility, such as long flights.

  • Hypercoagulability: Due to clotting disorders, pregnancy, or cancer.

  • Endothelial Damage: Resulting from surgery or trauma.

Complications

  • May lead to pulmonary embolism, where the clot dislodges and travels to the lungs, causing respiratory distress or even death.

Hypertension (HTN)

  • Definition: Persistent elevation of systolic blood pressure ≥ 130 mmHg or diastolic blood pressure ≥ 80 mmHg.

Types

  • Primary (Essential) Hypertension: Accounts for 90-95% of cases, with no identifiable cause. Linked to genetic predisposition, lifestyle, and aging.

  • Secondary Hypertension: Accounts for 5-10%, stemming from underlying conditions (e.g., kidney disease, endocrine disorders, medication-induced).

Pathophysiology

  • Increased sympathetic nervous system activity results in vasoconstriction and increased heart rate.

  • Overactivation of RAAS leads to sodium retention and vasoconstriction.

  • Endothelial dysfunction results in reduced nitric oxide (a vasodilator) and increased endothelin (a vasoconstrictor).

Risk Factors

  • Include age, gender and race, family history, dietary factors, tobacco use, alcoholism, and obesity.

Complications

  • Cardiovascular complications include left ventricular hypertrophy leading to heart failure.

  • Neurological complications include stroke and cognitive impairment.

  • Renal complications may progress to chronic kidney disease.

  • Ophthalmic complications include hypertensive retinopathy, which can lead to vision loss.

Diagnosis

  • Method: Blood pressure measurement.

Management

  • Lifestyle Interventions: Low-salt diet, engaging in 30 minutes of exercise daily, achieving weight loss, and quitting smoking.

  • Medications: Include antihypertensives such as ACE inhibitors, beta-blockers, and diuretics.

Atherosclerosis

  • Definition: A progressive condition caused by the accumulation of fatty plaques in arterial walls, leading to narrowing and stiffening of arteries.

Pathophysiology

  • Initiated by endothelial injury from high blood pressure, smoking, diabetes, or hyperlipidemia, followed by lipid accumulation (LDL cholesterol) in arterial walls.

  • Inflammation causes macrophages to engulf LDL, forming foam cells and fatty streaks, followed by plaque formation as smooth muscle cells proliferate and form a fibrous cap over the fatty core.

Complications

  • Plaque rupture can lead to thrombosis resulting in myocardial infarction or stroke.

  • Chronic narrowing may cause ischemia, leading to angina or peripheral artery disease.

Risk Factors

  • Modifiable: Smoking, diet, a sedentary lifestyle, hypertension, and diabetes.

  • Non-modifiable: Age, genetic predisposition, and sex (males at higher risk).

Clinical Consequences

  • Coronary Artery Disease (CAD): Chest pain, heart attack.

  • Cerebrovascular Disease: Stroke or transient ischemic attacks (TIA).

  • Peripheral Artery Disease (PAD): Claudication, gangrene.

Coronary Heart Disease (CHD)/Coronary Artery Disease (CAD)/Ischemic Heart Disease (IHD)

  • Definition: Condition caused by narrowing or blocking of blood flow in the coronary arteries due to atherosclerosis.

Risk Factors

  • Non-modifiable: Old age, male gender (>40 years), women post-menopause (~55 years), family history.

  • Modifiable: Dyslipidemia, hypertension, smoking, diabetes or insulin resistance, obesity, sedentary lifestyle, and unhealthy diet.

Types

  • Stable Angina: Chest pain occurs predictably during exertion or stress and is relieved by rest or nitroglycerin.

  • Unstable Angina: Chest pain occurs unpredictably or at rest and is more severe, indicating a higher risk for myocardial infarction.

  • Myocardial Infarction (MI): Heart attack caused by complete blockage of a coronary artery, leading to death of heart muscle cells.